semaglutide and eye vision GLP-1 Drugs Diabetic Disease: Ozempic, Semaglutide, and Retinopathy Risk Ozempic linked to higher risk

All of the above suggest that abnormal dietary intake and defective metabolism of Met could result in the abnormal levels of Met and its metabolites (SAMe and GSH) and accumulation of toxic metabolic intermediates (Hcy, Hcythiolactone, and 3-MTP) in the liver, which in turn affects the functions and the inflammatory responses to damage/infection of the liver (Figure 4)

These are outcomes that change health trajectories, reduce comorbidity risks, and fundamentally alter quality of life

The dual GIP/GLP-1 action produces stronger and earlier appetite suppression for most patients

(PubMed) Pilar Valdecantos M, Prieto-Hontoria PL, Pardo V, et al